Erythropoietin and obesity-induced white adipose tissue inflammation: redefining the boundaries of the immunometabolism territory

References

• Zeyda M, Stulnig T: Obesity, inflammation and insulin resistance-a mini-review. Gerontology 2009; 55: 379-86; PMID:19365105; http://dx.doi.org/10.1159/000212758
   PubMed Web of Science ®Google Scholar
• Olefsky JM, Glass CK: Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72:219-46; PMID:20148674; http://dx.doi.org/10.1146/annurev-physiol-021909-135846
   PubMed Web of Science ®Google Scholar
• Lumeng CN, Saltiel AR: Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121(6): 2111-7; PMID:21633179; http://dx.doi.org/10.1172/JCI57132
   PubMed Web of Science ®Google Scholar
• Han JM and Levings MK. Immune regulation in obesity-associated adipose inflammation. J Immunol 2013; 191(2):527-32; PMID:23825387; http://dx.doi.org/10.4049/jimmunol.1301035
   PubMed Web of Science ®Google Scholar
• Schneider A, Schneider MP, Scharnagl H, Jardine AG, Wanner C, Drechsler C. Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes. BMC Nephrol 2013; 14: 67; PMID:23521816; http://dx.doi.org/10.1186/1471-2369-14-67
   PubMedGoogle Scholar
• Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol, 1992; 12: 5447-54
   PubMed Web of Science ®Google Scholar
• Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y. Survival and proliferation roles of erythropoietin beyond erythroid lineage. Expert Rev Mol Med 2008; 10:e36; PMID:19040789; http://dx.doi.org/10.1017/S1462399408000860
   PubMedGoogle Scholar
• Zhang Y, Wang L, Dey S, Alnaeeli M, Suresh S, Rogers H, Teng R, Noguchi CT. Erythropoietin action in stress response, tissue maintenance and metabolism. Int J Mol Sci 2014; 15(6):10296-333; PMID:24918289; http://dx.doi.org/10.3390/ijms150610296
   PubMed Web of Science ®Google Scholar
• Kertesz N, Wu J, Chen TH, Sucov HM, Wu H. The role of erythropoietin in regulating angiogenesis. Dev Biol 2004; 276: 101-10; PMID:15531367; http://dx.doi.org/10.1016/j.ydbio.2004.08.025
   PubMed Web of Science ®Google Scholar
• Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 2004; 104(7):2073-80; PMID:15205261; http://dx.doi.org/10.1182/blood-2004-02-0744
   PubMed Web of Science ®Google Scholar
• Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003; 198:971-5; PMID:12975460; http://dx.doi.org/10.1084/jem.20021067
   PubMed Web of Science ®Google Scholar
• Yuan R, Maeda Y, Li W, Lu W, Cook S, Dowling P. Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE. PLoS One 2008; 3:e1924; PMID:18382691; http://dx.doi.org/10.1371/journal.pone.0001924
   PubMed Web of Science ®Google Scholar
• Hojman P, Brolin C, Gissel H, Brandt C, Zerahn B, Pedersen BK, Gehl J. Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles. PLoS One 2009; 4(6):e5894; PMID:19521513; http://dx.doi.org/10.1371/journal.pone.0005894
   PubMed Web of Science ®Google Scholar
• Katz O, Stuible M, Golishevski N, Lifshitz L, Tremblay ML, Gassmann M, Mittelman M, Neumann D. Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models. J Endocrinol 2010; 205(1):87-95; PMID:20061512; http://dx.doi.org/10.1677/JOE-09-0425
   PubMed Web of Science ®Google Scholar
• Foskett A, Alnaeeli M, Wang L, Teng R, Noguchi CT. The effects of erythropoietin dose titration during high-fat diet-induced obesity. J Biomed Biotechnol 2011; 2011:373781; PMID:21541227
   PubMedGoogle Scholar
• Teng R, Gavrilova O, Suzuki N, Chanturiya T, Schimel D, Hugendubler L, Mammen S, Yver DR, Cushman SW, Mueller E, et al. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production. Nat Commun 2011; 2:520; PMID:22044999
   PubMedGoogle Scholar
• Pan Y, Shu JL, Gu HF, Zhou DC, Liu XL, Qiao QY, Fu SK, Gao FH, Jin HM. Erythropoietin improves insulin resistance via the regulation of its receptor-mediated signaling pathways in 3T3L1 adipocytes. Mol Cell Endocrinol 2013; 10; 367(1-2):116-23; PMID:23313788; http://dx.doi.org/10.1016/j.mce.2012.12.027
   PubMedGoogle Scholar
• Wang L, Teng R, Di L, Rogers H, Wu H, Kopp JB, Noguchi CT. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes 2013; 62(12):4122-31; PMID:23990359; http://dx.doi.org/10.2337/db13-0518
   PubMedGoogle Scholar
• Luk CT, Shi SY, Choi D, Cai EP, Schroer SA, Woo M. In vivo knockdown of adipocyte erythropoietin receptor does not alter glucose or energy homeostasis. Endocrinology 2013; 154(10):3652-9; PMID:23885016; http://dx.doi.org/10.1210/en.2013-1113
   PubMedGoogle Scholar
• Alnaeeli M, Raaka BM, Gavrilova O, Teng R, Chanturiya T, Noguchi CT. Erythropoietin signaling: A novel regulator of white adipose tissue inflammation during diet-induced obesity. Diabetes 2014; 63(7):2415-31; PMID:24647735; http://dx.doi.org/10.2337/db13-0883
   PubMedGoogle Scholar
• Nairz M, Schroll A, Moschen AR, Sonnweber T, Theurl M, Theurl I, Taub N, Jamnig C, Neurauter D, Huber LA, et al. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity 2011; 34(1):61-74; PMID:21256055; http://dx.doi.org/10.1016/j.immuni.2011.01.002
   PubMed Web of Science ®Google Scholar
• Lu KY, Ching LC, Su KH, Yu YB, Kou YR, Hsiao SH, Huang YC, Chen CY, Cheng LC, Pan CC, et al. Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha. Circulation 2010; 121(16): 1828-37; PMID:20385932; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.876839
   PubMedGoogle Scholar
• Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Speigelman BM. Increased adipose tissue expression of tumor necrosis factor- in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15; PMID:7738205; http://dx.doi.org/10.1172/JCI117936
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-808; PMID:14679176; http://dx.doi.org/10.1172/JCI200319246
   PubMed Web of Science ®Google Scholar
• Xu H, Banres GT, Yang Q, Tan G, Yan D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830; PMID:14679177; http://dx.doi.org/10.1172/JCI200319451
   PubMed Web of Science ®Google Scholar
• Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 2008; 14: 1225-30; PMID:18473870; http://dx.doi.org/10.2174/138161208784246153
   PubMed Web of Science ®Google Scholar
• Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15(8):914-20; PMID:19633658; http://dx.doi.org/10.1038/nm.1964
   PubMed Web of Science ®Google Scholar
• Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interaction with the insulin receptor and inhibits insulin action. J Biol Chem 2002; 277: 1531-7; PMID:11606564; http://dx.doi.org/10.1074/jbc.M101521200
   PubMed Web of Science ®Google Scholar
• Shoelson, SE, Lee J, Goldine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-108; PMID:16823477; http://dx.doi.org/10.1172/JCI29069
   PubMed Web of Science ®Google Scholar
• Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance and hepatic steatosis in obesity. J Clin Invest 2006; 116(6):1494-505; PMID:16691291; http://dx.doi.org/10.1172/JCI26498
   PubMed Web of Science ®Google Scholar
• Feral CC, Neels JG, Kummer C, Slepak M, Olefsky JM, Ginsberg MH. Blockade of 4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity. Diabetes 2008; 57: 1842-51; PMID:18426864; http://dx.doi.org/10.2337/db07-1751
   PubMedGoogle Scholar
• Westcott DJ, Delproposto JB, Geletka LM, Wang T, Singer K, Saltiel AR, Lumeng CN. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J Exp Med 2009; 206(13):3143-56; PMID:19995956; http://dx.doi.org/10.1084/jem.20091333
   PubMed Web of Science ®Google Scholar
• Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Säemann MD, Geyeregger R, Schlederer M, Kenner L, et al. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 2010; 59(4):935-46; PMID:20107108; http://dx.doi.org/10.2337/db09-0404
   PubMed Web of Science ®Google Scholar
• Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai, K, Sakamoto K, Kobayashi M. et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006; 281(36):26602-14; PMID:16809344; http://dx.doi.org/10.1074/jbc.M601284200
   PubMedGoogle Scholar
• Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007; 56(1):16-23; PMID:17192460; http://dx.doi.org/10.2337/db06-1076
   PubMedGoogle Scholar
• Choi D, Schroer SA, Lu SY, Wang L, Wu X, Liu Y, Zhang Y, Gaisano HY, Wagner KU, Wu H, et al. Erythropoietin protects against diabetes through direct effects on pancreatic beta cells. J Exp Med 2010; 207:2831-42; PMID:21149549; http://dx.doi.org/10.1084/jem.20100665
   PubMed Web of Science ®Google Scholar